A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia
Condition:   Idiopathic Hypersomnia Interventions:   Drug: Pitolisant Oral Tablet;   Drug: Placebo oral tablet Sponsor:   Harmony Biosciences, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2021 Category: Research Source Type: clinical trials

Idiopathic Hypersomnia
Condition:   Hypersomnia, Idiopathic Intervention:   Other: Polysomnography Sponsor:   Uppsala University Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 9, 2021 Category: Research Source Type: clinical trials